Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2001 Aug;56(8):643–648. doi: 10.1136/thorax.56.8.643

Transforming growth factor β2 induced pleurodesis is not inhibited by corticosteroids

Y Lee 1, C Devin 1, L Teixeira 1, J Rogers 1, P Thompson 1, K Lane 1, R Light 1
PMCID: PMC1746114  PMID: 11462068

Abstract

BACKGROUND—Talc and tetracyclines induce pleurodesis by directly injuring the pleura. The injury results in intense inflammation which subsequently leads to fibrosis. Corticosteroids can inhibit talc pleurodesis by reducing the inflammatory process. We hypothesised that transforming growth factor β2 (TGFβ2), a fibrogenic cytokine with immunomodulatory functions, could induce effective pleurodesis without generating significant pleural inflammation and therefore remain effective despite co-administration of corticosteroids.
METHODS—Thirty rabbits were divided into two groups. Rabbits in the steroid group received weekly intramuscular injections of triamcinolone diacetate (0.8 mg/kg). Ten rabbits in each group were given 5.0 µg TGFβ2 intrapleurally via a chest tube while the remaining five received 1.7 µg TGFβ2. Pleurodesis was graded macroscopically after 14 days from 1 (none) to 8 (>50% symphysis).
RESULTS—TGFβ2 produced excellent pleurodesis at both 5.0 µg and 1.7 µg doses. The pleural effusions produced after the injection were low in all inflammatory markers. No significant differences were seen between the steroid group and controls in macroscopic pleurodesis scores (7.2 (1.3) v 7.1 (1.2)), levels of inflammatory markers in the pleural fluids (leucocyte 1107 (387)/mm3v 1376 (581)/mm3; protein 3.1 (0.3) mg/dl v 2.9 (0.3) mg/dl, and LDH 478 (232) IU/l v 502 (123) IU/l), and the degree of microscopic pleural fibrosis and pleural inflammation.
CONCLUSIONS—TGFβ2 can induce effective pleurodesis and remains effective in the presence of high dose parenteral corticosteroids.



Full Text

The Full Text of this article is available as a PDF (161.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almawi W. Y., Beyhum H. N., Rahme A. A., Rieder M. J. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol. 1996 Nov;60(5):563–572. doi: 10.1002/jlb.60.5.563. [DOI] [PubMed] [Google Scholar]
  2. Andrade G. B., Riet-Correa F., Montes G. S., Battlehner C. N., Saldiva P. H. Dating of fibrotic lesions by the Picrosirius-polarization method. An application using the lesions of Lechiguana (bovine focal proliferative fibrogranulomatous panniculitis). Eur J Histochem. 1997;41(3):203–209. [PubMed] [Google Scholar]
  3. AyanlarBatuman O., Ferrero A. P., Diaz A., Jimenez S. A. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J Clin Invest. 1991 Nov;88(5):1574–1580. doi: 10.1172/JCI115469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baumgartner R. A., Deramo V. A., Beaven M. A. Constitutive and inducible mechanisms for synthesis and release of cytokines in immune cell lines. J Immunol. 1996 Nov 1;157(9):4087–4093. [PubMed] [Google Scholar]
  5. Beck L. S., DeGuzman L., Lee W. P., Xu Y., Siegel M. W., Amento E. P. One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing. J Clin Invest. 1993 Dec;92(6):2841–2849. doi: 10.1172/JCI116904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Berse B., Hunt J. A., Diegel R. J., Morganelli P., Yeo K., Brown F., Fava R. A. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol. 1999 Jan;115(1):176–182. doi: 10.1046/j.1365-2249.1999.00775.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Border W. A., Noble N. A. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994 Nov 10;331(19):1286–1292. doi: 10.1056/NEJM199411103311907. [DOI] [PubMed] [Google Scholar]
  8. Cheng D. S., Rogers J., Wheeler A., Parker R., Teixeira L., Light R. W. The effects of intrapleural polyclonal anti-tumor necrosis factor alpha (TNF alpha) Fab fragments on pleurodesis in rabbits. Lung. 2000;178(1):19–29. doi: 10.1007/s004080000003. [DOI] [PubMed] [Google Scholar]
  9. Correale J., Arias M., Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol. 1998 Oct 1;161(7):3365–3374. [PubMed] [Google Scholar]
  10. Danielpour D., Kim K. Y., Winokur T. S., Sporn M. B. Differential regulation of the expression of transforming growth factor-beta s 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells. J Cell Physiol. 1991 Aug;148(2):235–244. doi: 10.1002/jcp.1041480208. [DOI] [PubMed] [Google Scholar]
  11. Feige J. J., Cochet C., Savona C., Shi D. L., Keramidas M., Defaye G., Chambaz E. M. Transforming growth factor beta 1: an autocrine regulator of adrenocortical steroidogenesis. Endocr Res. 1991;17(1-2):267–279. doi: 10.1080/07435809109027201. [DOI] [PubMed] [Google Scholar]
  12. Gary Lee Y. C., Teixeira L. R., Devin C. J., Vaz M. A., Vargas F. S., Thompson P. J., Lane K. B., Light R. W. Transforming growth factor-beta2 induces pleurodesis significantly faster than talc. Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):640–644. doi: 10.1164/ajrccm.163.3.2002091. [DOI] [PubMed] [Google Scholar]
  13. Gupta P., Franco-Saenz R., Mulrow P. J. Transforming growth factor-beta 1 inhibits aldosterone biosynthesis in cultured bovine zona glomerulosa cells. Endocrinology. 1993 Mar;132(3):1184–1188. doi: 10.1210/endo.132.3.8440178. [DOI] [PubMed] [Google Scholar]
  14. Ikubo A., Morisaki T., Katano M., Kitsuki H., Anan K., Uchiyama A., Tanaka M., Torisu M. A possible role of TGF-beta in the formation of malignant effusions. Clin Immunol Immunopathol. 1995 Oct;77(1):27–32. doi: 10.1016/0090-1229(95)90133-7. [DOI] [PubMed] [Google Scholar]
  15. Kelly F. J., Anderson S., Thompson M. M., Oyama T. T., Kennefick T. M., Corless C. L., Roman R. J., Kurtzberg L., Pratt B. M., Ledbetter S. R. Acute and chronic renal effects of recombinant human TGF-beta2 in the rat. J Am Soc Nephrol. 1999 Jun;10(6):1264–1273. doi: 10.1681/ASN.V1061264. [DOI] [PubMed] [Google Scholar]
  16. Kennedy L., Harley R. A., Sahn S. A., Strange C. Talc slurry pleurodesis. Pleural fluid and histologic analysis. Chest. 1995 Jun;107(6):1707–1712. doi: 10.1378/chest.107.6.1707. [DOI] [PubMed] [Google Scholar]
  17. Khalil N., Whitman C., Zuo L., Danielpour D., Greenberg A. Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest. 1993 Oct;92(4):1812–1818. doi: 10.1172/JCI116771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Koli K., Keski-Oja J. Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily. Adv Cancer Res. 1996;70:63–94. doi: 10.1016/s0065-230x(08)60872-6. [DOI] [PubMed] [Google Scholar]
  19. Lee Y. C., Lane K. B., Parker R. E., Ayo D. S., Rogers J. T., Diters R. W., Thompson P. J., Light R. W. Transforming growth factor beta(2) (TGF beta(2)) produces effective pleurodesis in sheep with no systemic complications. Thorax. 2000 Dec;55(12):1058–1062. doi: 10.1136/thorax.55.12.1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Light R. W., Cheng D. S., Lee Y. C., Rogers J., Davidson J., Lane K. B. A single intrapleural injection of transforming growth factor-beta(2) produces an excellent pleurodesis in rabbits. Am J Respir Crit Care Med. 2000 Jul;162(1):98–104. doi: 10.1164/ajrccm.162.1.9909106. [DOI] [PubMed] [Google Scholar]
  21. Meisler N., Keefer K. A., Ehrlich H. P., Yager D. R., Myers-Parrelli J., Cutroneo K. R. Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts. J Invest Dermatol. 1997 Mar;108(3):285–289. doi: 10.1111/1523-1747.ep12286461. [DOI] [PubMed] [Google Scholar]
  22. Ogawa Y., Seyedin S. M. Purification of transforming growth factors beta 1 and beta 2 from bovine bone and cell culture assays. Methods Enzymol. 1991;198:317–327. doi: 10.1016/0076-6879(91)98032-2. [DOI] [PubMed] [Google Scholar]
  23. Oursler M. J., Riggs B. L., Spelsberg T. C. Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. Endocrinology. 1993 Nov;133(5):2187–2196. doi: 10.1210/endo.133.5.8404670. [DOI] [PubMed] [Google Scholar]
  24. Pierce G. F., Mustoe T. A., Lingelbach J., Masakowski V. R., Gramates P., Deuel T. F. Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2229–2233. doi: 10.1073/pnas.86.7.2229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Slavin J., Nash J. R., Kingsnorth A. N. Effect of transforming growth factor beta and basic fibroblast growth factor on steroid-impaired healing intestinal wounds. Br J Surg. 1992 Jan;79(1):69–72. doi: 10.1002/bjs.1800790124. [DOI] [PubMed] [Google Scholar]
  26. Smith W. B., Noack L., Khew-Goodall Y., Isenmann S., Vadas M. A., Gamble J. R. Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J Immunol. 1996 Jul 1;157(1):360–368. [PubMed] [Google Scholar]
  27. Sporn M. B., Roberts A. B. Peptide growth factors are multifunctional. Nature. 1988 Mar 17;332(6161):217–219. doi: 10.1038/332217a0. [DOI] [PubMed] [Google Scholar]
  28. Stoloff S., Stempel D. A. Churg-Strauss syndrome: is there an association with leukotriene modifiers? Chest. 2000 Nov;118(5):1515–1516. doi: 10.1378/chest.118.5.1515. [DOI] [PubMed] [Google Scholar]
  29. Terrell T. G., Working P. K., Chow C. P., Green J. D. Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits. Int Rev Exp Pathol. 1993;34(Pt B):43–67. doi: 10.1016/b978-0-12-364935-5.50009-2. [DOI] [PubMed] [Google Scholar]
  30. Tsao T., Fawcett J., Fervenza F. C., Hsu F. W., Huie P., Sibley R. K., Rabkin R. Expression of insulin-like growth factor-I and transforming growth factor-beta in hypokalemic nephropathy in the rat. Kidney Int. 2001 Jan;59(1):96–105. doi: 10.1046/j.1523-1755.2001.00470.x. [DOI] [PubMed] [Google Scholar]
  31. Vargas F. S., Teixeira L. R., Antonangelo L., Silva L. M., Strunz C. M., Light R. W. Acute and chronic pleural changes after the intrapleural instillation of mitoxantrone in rabbits. Lung. 1998;176(4):227–236. doi: 10.1007/pl00007605. [DOI] [PubMed] [Google Scholar]
  32. Vargas F. S., Teixeira L. R., Silva L. M., Carmo A. O., Light R. W. Comparison of silver nitrate and tetracycline as pleural sclerosing agents in rabbits. Chest. 1995 Oct;108(4):1080–1083. doi: 10.1378/chest.108.4.1080. [DOI] [PubMed] [Google Scholar]
  33. Wang J., Kuliszewski M., Yee W., Sedlackova L., Xu J., Tseu I., Post M. Cloning and expression of glucocorticoid-induced genes in fetal rat lung fibroblasts. Transforming growth factor-beta 3. J Biol Chem. 1995 Feb 10;270(6):2722–2728. doi: 10.1074/jbc.270.6.2722. [DOI] [PubMed] [Google Scholar]
  34. Xie C., McGovern J. P., Wu W., Wang N. S., Light R. W. Comparisons of pleurodesis induced by talc with or without thymol iodide in rabbits. Chest. 1998 Mar;113(3):795–799. doi: 10.1378/chest.113.3.795. [DOI] [PubMed] [Google Scholar]
  35. Xie C., Teixeira L. R., McGovern J. P., Light R. W. Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1441–1444. doi: 10.1164/ajrccm.157.5.9708032. [DOI] [PubMed] [Google Scholar]
  36. Xie C., Teixeira L. R., Wang N., McGovern J. P., Light R. W. Serial observations after high dose talc slurry in the rabbit model for pleurodesis. Lung. 1998;176(5):299–307. doi: 10.1007/pl00007612. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES